par Bolla, M.;Van Poppel, H;Tombal, Bertrand;Vekemans, Kris;Da Pozzo, Luigi;De Reijke, Theo M.;Verbaeys, Antony;Bosset, Jean François;Van Velthoven, Roland
;Colombel, M;van de Beek, Cees;Verhagen, Paul;Van den Bergh, A.;Sternberg, Cora;Gasser, Thomas;Van Tienhoven, Geertjan;Scalliet, Pierre;Haustermans, Karin;Collette, Laurence;European Organisation for Research and Treatment of Cancer,
Référence Lancet, 380, 9858, page (2018-2027)
Publication Publié, 2012-12

Référence Lancet, 380, 9858, page (2018-2027)
Publication Publié, 2012-12
Article révisé par les pairs
Titre: |
|
Auteur: | Bolla, M.; Van Poppel, H; Tombal, Bertrand; Vekemans, Kris; Da Pozzo, Luigi; De Reijke, Theo M.; Verbaeys, Antony; Bosset, Jean François; Van Velthoven, Roland; Colombel, M; van de Beek, Cees; Verhagen, Paul; Van den Bergh, A.; Sternberg, Cora; Gasser, Thomas; Van Tienhoven, Geertjan; Scalliet, Pierre; Haustermans, Karin; Collette, Laurence; European Organisation for Research and Treatment of Cancer, |
Informations sur la publication: | Lancet, 380, 9858, page (2018-2027) |
Statut de publication: | Publié, 2012-12 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Aged |
Combined Modality Therapy -- methods | |
Disease-Free Survival | |
Humans | |
Male | |
Middle Aged | |
Neoplasm Recurrence, Local -- mortality | |
Postoperative Care -- mortality | |
Prostatectomy -- methods -- mortality | |
Prostatic Neoplasms -- mortality -- radiotherapy -- surgery | |
Treatment Outcome | |
Watchful Waiting | |
Note générale: | Clinical Trial, Phase III |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0140-6736 |
info:doi/10.1016/S0140-6736(12)61253-7 | |
info:pii/S0140-6736(12)61253-7 | |
info:scp/84870485783 | |
info:pmid/23084481 |